Page 4,683«..1020..4,6824,6834,6844,685..4,6904,700..»

Scottsdale Plastic Surgeon Dr. Brown Accepted into American Society for Aesthetic Plastic Surgeons

Posted: Published on January 20th, 2014

Scottsdale, AZ (PRWEB) January 20, 2014 Scottsdale plastic surgeon, Dr. Richard J. Brown, is proud to announce he has recently been accepted into the American Society for Aesthetic Plastic Surgeons (ASAPS). Dr. Brown is the founder of the renowned Scottsdale plastic surgery office, Richard J. Brown MD, PLLC. ASAPS membership in the U.S. is restricted to American Board of Plastic Surgery (ABPS) certified surgeons who are also recommended by their peers for having an outstanding professional reputation. "I am excited to have been accepted by our most prestigious cosmetic society, said Scottsdale plastic surgeon, Dr. Richard Brown. I have put in many years of hard work and dedication to get where I am today. This is validation that hard work does pay off. I am honored to be accepted by the American Society or Aesthetic Plastic Surgeons as a qualified, board certified Plastic Surgeon. The ASAPS was founded in 1967 and is the leading professional organization of plastic surgeons certified by the ABPS who specialize in cosmetic plastic surgery. It has over 2,600 members in the U.S., Canada, and other countries. Dr. Brown specializes in cosmetic and reconstructive surgery of the face, body, breast and extremities. Richard J. Brown MD, … Continue reading

Posted in Aesthetic Surgery | Comments Off on Scottsdale Plastic Surgeon Dr. Brown Accepted into American Society for Aesthetic Plastic Surgeons

Induced Pluripotent Stem Cell Human Trial | National Review Online

Posted: Published on January 20th, 2014

The first induced pluripotent stem cell human trialthat is, ethical stem cells made from skin or other tissuesis about to begin. Like the two (or is it three?) existing embryonic stem cell trials, it has to do with eye disease. From the Nature News story: On 1 August, researchers at the RIKEN Center for Developmental Biology in Kobe, Japan, will start recruiting patients for theworlds first clinical studyusing induced pluripotent stem (iPS) cells.RIKENs endorsement, officially announced today, was the final stage in a long series of regulatory steps that included approval from the health ministry. Ophthalmologist Masayo Takahashi will be using sheets of retinal pigment epithelium cells, derived from iPS cells, to try to halt the progression of age-related macular degeneration. In the wet-type AMD targeted by Takahashi, abnormal vascularization invades and destabilizes the epithelium, which supports the photoreceptors, and causes loss of vision. IPScslike embryonic stem cellscarry a pronounced danger of causing tumors with rare exceptionssuch as in these eye diseases. But adult stem cells dont have that difficulty and are currently in thousands of human trials around the worldfor heart disease, paralysis, MS, etc.along with some already approved clinical applications. Remember when George Bushwas anti science forclaiming that … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Induced Pluripotent Stem Cell Human Trial | National Review Online

Parkinson's Disease sufferer from York pressing ahead with trip to Kiev for pioneering treatment, despite political …

Posted: Published on January 20th, 2014

Parkinson's Disease sufferer from York pressing ahead with trip to Kiev for pioneering treatment, despite political turmoil 2:49pm Monday 20th January 2014 in News By Mike Laycock, Chief reporter A PARKINSONS Disease sufferer from York is pressing ahead with a trip to Ukraine for pioneering stem cell treatment - despite growing political turmoil and personal difficulties in getting insurance. The Press reported earlier this month how James DeLittle, 49, of Broadway West, Fulford, was hoping the two-day course in the capital Kiev will tackle his worsening condition, lessening symptoms such as poor balance, tremor, difficulties controlling his limbs and slurred speech. The treatment, which involves foetal stem cells being injected into his stomach and arms, will cost about 7,000. The former St Peters School pupil believes he will be the first person from the UK to receive it. His mother Rosemary revealed yesterday (mon) that after reading the newspapers report, several relatives and friends of the family had made additional donations towards the bill, including one man who had known James late father when he was a child and had sent a cheque for 100. I was very touched, she said. She said she had been worried about the impact … Continue reading

Comments Off on Parkinson's Disease sufferer from York pressing ahead with trip to Kiev for pioneering treatment, despite political …

Atossa Genetics (ATOS) Multiple Bottom Pattern – Video

Posted: Published on January 19th, 2014

Atossa Genetics (ATOS) Multiple Bottom Pattern The Atossa Genetics chart has made a multiple bottom pattern on a solid support at $2.20. The last to moves off this point rose to approximately $3, suggesti... By: AllPennyStocks … Continue reading

Posted in Genetics | Comments Off on Atossa Genetics (ATOS) Multiple Bottom Pattern – Video

MUSHROOM CLOUD – MALAYALAM – Fun with chemistry! – Video

Posted: Published on January 19th, 2014

MUSHROOM CLOUD - MALAYALAM - Fun with chemistry! When you place a high density drop in a low-density liquid the effect is called as Rayleigh-Taylor Effect and results in formation of a mushroom cloud or vor... By: Arvind Gupta … Continue reading

Posted in Chemistry | Comments Off on MUSHROOM CLOUD – MALAYALAM – Fun with chemistry! – Video

JPMorgan Healthcare Conference Highlights: Sarepta Therapeutics

Posted: Published on January 19th, 2014

The past four days have brought together pharmaceutical, biotechnology, and medical device makers all under one roof in what is arguably the most important health care conference of the year, the 2014 JPMorgan Healthcare Conference. Just like the recently concluded Consumer Electronics Show in Las Vegas, this annual event gives health care companies a chance to demonstrate to investors and Wall Street where they've been and where they're headed. Because earnings guidance can be somewhat irrelevant for clinical-stage biotech and medical device companies, consider this event your chance to gain guidance from some 300 top health care companies. Today, we're going to take a closer look atSarepta Therapeutics' (NASDAQ: SRPT) presentation, which was delivered Wednesday by President and CEO Chris Garabedian. Sarepta Therapeutics' past year Like many of the companies we've chronicled this week, Sarepta's had a wild ride over the past year, flying high at one point on continued follow-up data of its relatively small midstage study of eteplirsen for Duchenne muscular dystrophy, or DMD, a disorder that results in muscle degeneration and early death in boys. Shares of Sarepta climbed to a 52-week high of $55.61 in September shortly after an experimental rival drug, drisapersen, developed by Prosensa … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on JPMorgan Healthcare Conference Highlights: Sarepta Therapeutics

Autism Treatment Center Of America by theHealthFoodGuru com – Video

Posted: Published on January 19th, 2014

Autism Treatment Center Of America by theHealthFoodGuru com https://theHealthFoodGuru.com - Your ALL-IN-ONE Autism Nutrition! Never Buy Vitamins and Supplements Again! REAL Nutrition Delivered To Your Door Every Month... By: Bryan Foster … Continue reading

Comments Off on Autism Treatment Center Of America by theHealthFoodGuru com – Video

Maine examines expanding autism treatment coverage

Posted: Published on January 19th, 2014

By ALANNA DURKIN/Associated Press/January 19, 2014 AUGUSTA, Maine (AP) More children would receive private insurance coverage for autism treatment under a bill being considered by Maine lawmakers. But the price tag it carries gives it an uncertain future in the Democrat-controlled Legislature this session. Current law, which mandates that insurance companies provide coverage for treatment of autism spectrum disorder only for children ages 5 and under, is preventing families from getting effective, proven treatment for their children or forcing them onto Medicaid, say advocates who are pushing for the bill that would raise that age to 21. Were basically boxing people into a corner, said Nancy Cronin, executive director of the Maine Developmental Disabilities Council. Medicaid now covers applied behavior analysis treatment a regimen that psychiatric and medical professionals say is the most effective and promising for autistic children if their autism is so severe that they would be institutionalized without treatment. But families may not want to go onto Medicaid or their child may have a mild form of autism, preventing them from qualifying for the approach that teaches children skills by breaking them down into smaller skills, she said. Furthermore, many children arent diagnosed with autism until theyre … Continue reading

Comments Off on Maine examines expanding autism treatment coverage

Sandy Hook Panel To Receive Lanza Treatment Records

Posted: Published on January 19th, 2014

HARTFORD The Sandy Hook Advisory Commission secured a promise Friday from Peter Lanza to turn over at least some of Newtown shooter Adam Lanza's treatment records, and heard from two of the foremost autism experts on what the disorder isn't, as much as what it is. Peter Lanza "called me during the last presentation,'' Sandy Hook panel Chairman Scott Jackson said before the commission broke for lunch Friday afternoon. "I'm going to sit down with him in short order" to work out the parameters of a records release. Jackson, the mayor of Hamden, said earlier Friday that Peter Lanza had reached out to him recently and promised to help the commission in its quest to better understand what drove Lanza's son to kill 26 children and women at Sandy Hook Elementary School on Dec. 14, 2012, and to analyze Connecticut's mental health system for gaps and breakdowns. Peter Lanza's commitment was one step on that journey Friday; another was hearing Dr. Fred R. Volkmar of Yale and Matthew D. Lerner of Stony Brook University in New York cite study after study showing no link between autism spectrum disorders and violent crime. Adam Lanza "displayed a profound autism spectrum disorder with … Continue reading

Comments Off on Sandy Hook Panel To Receive Lanza Treatment Records

Police admit fault as Wath man, 26, is left brain damaged

Posted: Published on January 19th, 2014

South Yorkshire Police has admitted failings after a Wath man hit over the head with a metal pole was left in a cell for ten hours without medical treatment. Dean Hutton suffered serious brain damage in an attack by brothers Brett and James Garbutt in Rotherham in 2009 but was arrested and taken to a police station, where he was dismissed as drunk. The 26-year-old, who now needs lifelong care, has taken the next step in his battle for justice as the police admitted their failure to get him treatment sooner led to his further suffering. Paramedics checked Dean at the scene but when police arrived they arrested him for missing a traffic offence court appearance and he was taken to the station and put in a cell. It was only after his condition deteriorated over ten hours that he was eventually taken to hospital, where it emerged he had a fractured skull and bleeding to his brain. Visit link: Police admit fault as Wath man, 26, is left brain damaged … Continue reading

Posted in Brain Injury Treatment | Comments Off on Police admit fault as Wath man, 26, is left brain damaged

Page 4,683«..1020..4,6824,6834,6844,685..4,6904,700..»